55 results
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
have adopted an amended and restated compensation policy regarding the terms of engagement of office holders, which our shareholders approved on June 3 … engagement of the controlling shareholder of the Company or such controlling shareholder’s relative (even if such terms are not extraordinary) requires
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
of association.
We have adopted an amended and restated compensation policy regarding the terms of engagement of office holders, which our shareholders … or other engagement of the controlling shareholder of the Company or such controlling shareholder’s relative (even if such terms are not extraordinary
8-K
o739x2rsimq7kj7
11 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
eg5iim46fl 33e1x1vo
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
8-K
06bmhweya7t1ko
13 Jun 22
Departure of Directors or Certain Officers
4:55pm